FDA Warning Letter — Hi Nabor
The FDA took a Warning Letter action against Hi Nabor on Feb 2, 2017 (Baton Rouge, LA). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Hi Nabor
- Date
- Feb 2, 2017
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Baton Rouge, LA (United States)